Sarah Fitt: Pharmac CEO on the $1.7 billion funding-boost in the upcoming Budget

Pharmac's record funding-boost will address the fiscal cliff it faces.  An additional $1.7 billion spread over four-years has been ear-marked for the drug-buying agency in the upcoming Budget.  Chief Executive Sarah Fitt told Mike Hosking that the extra cash covers time-limited funding for some treatments, which ends this year.  She says the fiscal hole was always known, as the funds outlined in Budget 2022 only went through to Budget 2024.  LISTEN ABOVE   See omnystudio.com/listener for privacy information.